glp 1 new indications GLP-1 in 2026: The Research Frontier Explained GLP-1s like semaglutide are not

Since 2020, the number of prescriptions for GLP-1 drugs has more than tripled

Furthermore, SGLT-2i have been linked to elevated SCFA levels in the colon, specifically butyrate and acetate, which are known to affect insulin sensitivity, glucose homeostasis, and appetite control and protect from kidney and cardiovascular disease [14, 35]

It is a self-reinforcing cycle that is hard to interrupt with any single intervention

This aligns with the general recommendations for managing how semaglutide makes you feel day by day

Semaglutide is approved as a treatment for type 2 diabetes under the brand name Ozempic, semaglutide has gained significant recognition for its effectiveness in promoting substantial weight loss